When surgeons removed a 33-year-old woman’s right lung as part of her cancer treatment in 1995, they expected a dramatic and permanent reduction in her breathing power. But that’s not what happened.
Because evidence gaps in idiopathic pulmonary fibrosis research hinder demonstration of antifibrotic therapies’ impact on patient quality of life (QOL), integrating validated health-related QOL ...
“She never wanted anyone to have to naively be in pain without answers," Dern tells PEOPLE of her mother, who died in November 2025 Bailey Richards is a writer-reporter at PEOPLE. She has been working ...
ACE inhibitors may reduce all-cause mortality in IPF patients, suggesting potential repurposing for this progressive disease. The study used electronic health records from 3579 IPF patients, matched ...
SAN DIEGO--(BUSINESS WIRE)--Endeavor BioMedicines (“Endeavor”), a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients ...
Human lung tissue analyses identify iNKT cell depletion as a mechanistic feature of advanced IPFFindings extend MiNK’s iNKT platform into chronic ...
Humans can’t survive without taking a breath. And the lungs are the pneumatic engines that take in oxygen to be distributed throughout the body. As long as air goes in and out every 3–5 seconds, and ...
Deupirfenidone, a potential new treatment for idiopathic pulmonary fibrosis, is set to be tested in a phase 3 trial this year after a successful phase 2b trial and meeting with the FDA, according to a ...
Our lungs are amazing, quietly doing their thing to keep us breathing and alive. But when they are compromised by disease, the effects can be devastating. Two of the diseases that can have a serious ...
Targeting ACVRL1, dubbed an 'overlooked' gene by researchers, could potentially lead to new treatments for IPF, a study suggests.
Lung (pulmonary) sarcoma is a rare type of cancer that forms in the blood vessels and supportive tissue in your lungs. Most lung cancers, including small cell and non small cell lung cancers, are ...